Mr Thomas Scarborough, OTR/L | |
3867 Bayou Acres Dr, Bastrop, LA 71220-9232 | |
(318) 283-2080 | |
Not Available |
Full Name | Mr Thomas Scarborough |
---|---|
Gender | Male |
Speciality | Occupational Therapy |
Experience | 7 Years |
Location | 3867 Bayou Acres Dr, Bastrop, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831857259 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 308020 (Louisiana) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Orthopaedic Clinic Of Monroe | 0840252698 | 34 |
News Archive
An executive from the Verizon Connected Healthcare Solutions practice group will participate in a panel discussion at the World Health Congress Leadership Summit on Health Information Technology on Nov. 9 in Alexandria.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease.
› Verified 5 days ago
Provider Name | Orthopaedic Clinic Of Monroe |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1144266511 PECOS PAC ID: 0840252698 Enrollment ID: O20041103000304 |
News Archive
An executive from the Verizon Connected Healthcare Solutions practice group will participate in a panel discussion at the World Health Congress Leadership Summit on Health Information Technology on Nov. 9 in Alexandria.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Thomas Scarborough, OTR/L 100 Blue Jay Dr, Monroe, LA 71203-8871 Ph: () - | Mr Thomas Scarborough, OTR/L 3867 Bayou Acres Dr, Bastrop, LA 71220-9232 Ph: (318) 283-2080 |
News Archive
An executive from the Verizon Connected Healthcare Solutions practice group will participate in a panel discussion at the World Health Congress Leadership Summit on Health Information Technology on Nov. 9 in Alexandria.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease.
› Verified 5 days ago
Alyssa Brown, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3867 Bayou Acres Drive, 3867 Bayou Acres Drive, Bastrop, LA 71220 Phone: 318-283-2080 | |
Daylight Therapy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 461 E Madison Ave, Bastrop, LA 71220 Phone: 318-417-4848 |